News

COST Innovators Grant: 4 applications approved

Published on | 5 years ago

Programmes COST COST

The Committee of Senior Officials (CSO) has approved the funding for 4 COST Innovators Grants (CIG). 

The COST Innovators Grant aims at enhancing the pace and success of breakthrough innovations, to build bridges between the scientific research performed in COST Actions and marketable applications and/or societal solutions and to explore innovation potential.

An overview of the approved COST Innovators Grants:

  • CIG-15102: Innovative and sustainable TecHnologies for reducing critical raw mAterials dependence for Cleaner transportation Applications 
  • CIG-15104: Industrial Machine Monitoring unplugged network 
  • CIG-15114: ePlatform for a “test bed” tool across EU for antimicrobial coating solutions in health care entering to the market 
  • CIG-15119: Nanofluids for convective heat transfer devices 

The full COST press release can be found here: https://www.cost.eu/news/cost-innovators-grant-4-applications-approved/

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1602 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.